A detailed history of Grimes & Company, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Grimes & Company, Inc. holds 88,042 shares of PFE stock, worth $2.44 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
88,042
Previous 100,071 12.02%
Holding current value
$2.44 Million
Previous $2.88 Million 15.2%
% of portfolio
0.08%
Previous 0.1%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$25.89 - $29.73 $311,430 - $357,622
-12,029 Reduced 12.02%
88,042 $2.44 Million
Q4 2023

Jan 24, 2024

BUY
$26.13 - $33.94 $378,571 - $491,722
14,488 Added 16.93%
100,071 $2.88 Million
Q3 2023

Oct 19, 2023

SELL
$32.09 - $37.51 $14,633 - $17,104
-456 Reduced 0.53%
85,583 $2.84 Million
Q2 2023

Jul 19, 2023

SELL
$36.12 - $41.79 $131,476 - $152,115
-3,640 Reduced 4.06%
86,039 $3.16 Million
Q1 2023

Apr 20, 2023

BUY
$39.39 - $51.28 $319,571 - $416,034
8,113 Added 9.95%
89,679 $3.66 Million
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $34,402 - $44,908
824 Added 1.02%
81,566 $0
Q3 2022

Oct 28, 2022

BUY
$43.76 - $53.42 $4,157 - $5,074
95 Added 0.12%
80,742 $3.53 Million
Q2 2022

Jul 22, 2022

BUY
$46.53 - $55.17 $6,560 - $7,778
141 Added 0.18%
80,647 $4.23 Million
Q1 2022

May 06, 2022

SELL
$45.75 - $56.69 $2,516 - $3,117
-55 Reduced 0.07%
80,506 $4.17 Million
Q4 2021

Feb 01, 2022

SELL
$41.32 - $61.25 $17,271 - $25,602
-418 Reduced 0.52%
80,561 $4.76 Million
Q3 2021

Nov 08, 2021

SELL
$39.25 - $50.42 $43,057 - $55,310
-1,097 Reduced 1.34%
80,979 $3.48 Million
Q2 2021

Aug 04, 2021

SELL
$35.91 - $40.68 $133,764 - $151,533
-3,725 Reduced 4.34%
82,076 $3.21 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $324,551 - $366,029
9,691 Added 12.73%
85,801 $3.11 Million
Q4 2020

Feb 02, 2021

BUY
$33.47 - $42.56 $33,202 - $42,219
992 Added 1.32%
76,110 $2.8 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $12,446 - $14,602
392 Added 0.52%
75,118 $2.76 Million
Q2 2020

Jul 31, 2020

BUY
$30.12 - $36.54 $2,801 - $3,398
93 Added 0.12%
74,726 $2.44 Million
Q1 2020

May 05, 2020

BUY
$27.03 - $38.62 $133,230 - $190,357
4,929 Added 7.07%
74,633 $2.44 Million
Q4 2019

Feb 05, 2020

SELL
$32.92 - $37.36 $119,433 - $135,542
-3,628 Reduced 4.95%
69,704 $2.73 Million
Q3 2019

Nov 05, 2019

BUY
$32.49 - $42.13 $1,689 - $2,190
52 Added 0.07%
73,332 $2.5 Million
Q2 2019

Jul 30, 2019

SELL
$36.98 - $41.52 $14,976 - $16,815
-405 Reduced 0.55%
73,280 $3.18 Million
Q1 2019

May 02, 2019

SELL
$37.5 - $41.2 $1,537 - $1,689
-41 Reduced 0.06%
73,685 $3.13 Million
Q4 2018

Feb 01, 2019

SELL
$38.47 - $43.86 $173,807 - $198,159
-4,518 Reduced 5.77%
73,726 $3.22 Million
Q3 2018

Nov 09, 2018

BUY
$34.47 - $41.81 $39,812 - $48,290
1,155 Added 1.5%
78,244 $3.45 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $18,897 - $20,146
-573 Reduced 0.74%
77,089 $2.8 Million
Q1 2018

May 07, 2018

BUY
$31.91 - $37.02 $337,001 - $390,968
10,561 Added 15.74%
77,662 $2.76 Million
Q4 2017

Feb 05, 2018

BUY
$33.26 - $35.29 $304,096 - $322,656
9,143 Added 15.78%
67,101 $2.43 Million
Q3 2017

Nov 03, 2017

BUY
$31.0 - $34.15 $1.8 Million - $1.98 Million
57,958
57,958 $2.07 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $155B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.